$213 | SAVE $37 | Single User
$425 | SAVE $75 | Site License
$638 | SAVE $112 | Global License

ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Report Updated: 13-08-2018]

Published by Global Data: 13 Aug 2018 | 220705 | In Stock
Related Topics: Healthcare

Introduction

Summary

ChemRar High-Tech Center (CHTC) is a developer of drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system, infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including screening and identification of the important biological targets for new molecules, synthesis and research of new molecules, and manufacturing. CHTC also invests in companies with drug candidates in early development stage. The company serves its clients in Japan and Russia. CHTC is headquartered in Khimki, Russia.

ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-08-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deal Details 12

    Partnerships 12

    ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 12

    Regen BioPharma Enters into Agreement with ChemDiv 13

    Janssen Research & Development Enters into Agreement with ChemDiv 14

    ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 15

    National Immunobiological Forms Joint Venture with ChemRar HTC 16

    ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 17

    ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 18

    ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 19

    Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 20

    MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 21

    Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 22

    ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 23

    Licensing Agreements 24

    NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 24

    Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 25

    Equity Offering 26

    Viriom Raises USD2.35 Million in Private Placement of Shares 26

    ChemRar High-Tech Center - Key Competitors 27

    ChemRar High-Tech Center - Key Employees 28

    ChemRar High-Tech Center - Locations And Subsidiaries 29

    Head Office 29

    Other Locations & Subsidiaries 29

    Joint Venture 30

    Appendix 31

    Methodology 31

    About GlobalData 31

    Contact Us 31

    Disclaimer 31

List Of Tables
in ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-08-2018]

List of Tables

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Key Facts 2

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ChemRar High-Tech Center, Deals By Therapy Area, 2012 to YTD 2018 8

ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 12

Regen BioPharma Enters into Agreement with ChemDiv 13

Janssen Research & Development Enters into Agreement with ChemDiv 14

ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 15

National Immunobiological Forms Joint Venture with ChemRar HTC 16

ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 17

ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 18

ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 19

Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 20

MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 21

Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 22

ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 23

NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 24

Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 25

Viriom Raises USD2.35 Million in Private Placement of Shares 26

ChemRar High-Tech Center, Key Competitors 27

ChemRar High-Tech Center, Key Employees 28

ChemRar High-Tech Center, Subsidiaries 29

ChemRar High-Tech Center, Joint Venture 30

List Of Figures, Charts and Diagrams
in ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-08-2018]

List of Figures

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

220705 | GDPH336922D

Number of Pages

31

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a discovers and commercializes drugs for life-threatening ...
13 Apr 2018 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a discovers and commercializes drugs for life-threatening ...
27 Feb 2018 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a discovers and commercializes drugs for life-threatening ...
15 Nov 2017 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a discovers and commercializes drugs for life-threatening ...
26 Jul 2017 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops and comme...
23 Feb 2017 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops and comme...
24 Nov 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops and comme...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops, and comm...
06 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops, and comm...
10 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info

This report is published by Global Data

Download Free Report Summary PDF

ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-08-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...